Virion Therapeutics Company
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Technology:
Viral Vectors
Industry:
Viral Vectors
Headquarters:
Newark, Delaware, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
115000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-08-24
Last Funding Type:
Debt Financing
Register and Claim Ownership